Overview Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis Status: Not yet recruiting Trial end date: 2025-11-01 Target enrollment: Participant gender: Summary This clinical trial was multicenter, randomized, double-blind, placebo-controlled, parallel, phase III bridge study. Phase: Phase 3 Details Lead Sponsor: Pharmbio Korea Co., Ltd.